Boxer Capital
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Series A, Series B, Late Stage, Growth, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Denmark, Switzerland, Mexico, South Korea, Netherlands, South Africa, Sweden, Israel, Norway, Finland
Industries Focus
- Healthcare
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Regenerative Medicine
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Infectious Diseases
- Immunology
- Genomics
- Rare Diseases
Investment Size:
5,000,000 to 100,000,000 USD
Investor Details Founded: 2005
Boxer Capital is a private biotechnology investment firm based in San Diego, California, dedicated to fundamental, research-based investing in specialized and precision medicine companies across private and public markets. Founded in 2005, the firm has nearly two decades of experience in identifying and funding innovative biotechnology companies. Their team includes scientists and clinicians who have led research and discovery across multiple therapeutic indications, combining scientific expertise with investment experience to structure a repeatable process of bottom-up idea generation with top-down oversight from their founder.
The firm's investment philosophy focuses on identifying opportunities centered around transformative medical advancements in precision medicine. They invest across the drug life cycle, responding to changes in the biotechnology ecosystem and investment opportunity set. Boxer Capital seeks investments with a differentiated approach, clear rationale, and the right management team through lenses such as scientific, clinical, commercial, and regulatory. Their goal is to unlock better patient care and medicine for all through fundamental, scientific research, leveraging the predictive value of their team's fundamental due diligence to identify early-stage investments centered around novel, innovative drug targets.
Requirements
- Strong management team
- Innovative drug targets
- Potential for transformative medical advancements
- Alignment with Boxer Capital's investment philosophy
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Achilles Therapeutics
- Mirati Therapeutics
- AveXis Inc.
- BeiGene Ltd.
- Blueprint Medicines Corporation
- Cougar Biotechnology
- Tyra Biosciences
- Prometheus Biosciences
Mentioned In
Claim this Investor
Are you an official representative of Boxer Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim